logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11684605 B1

PDFFull Text
Date of Patent:
Jun. 27, 2023

Filed:

Oct. 06, 2021

Lisinopril compositions with an ingestible event marker

Applicant:

Otsuka Pharmaceutical Co., Ltd., Tokyo, JP;

Inventors:

Kurt Scheinpflug, Dublin, CA (US);

Nikhil Pargaonkar, Hayward, CA (US);

Chris Dong, Redwood City, CA (US);

Ai Ling Ching, San Francisco, CA (US);

Dawn Adkin, Loughborough, GB;

Assignee:

OTSUKA PHARMACEUTICAL CO., LTD., Tokyo, JP;

Attorney:

Pillsbury Winthrop Shaw Pittman LLP

Primary Examiner:

Daniel Previl

Int. Cl.
CPC ...
G08B 21/04 (2006.01); A61K 31/401 (2006.01); A61B 5/07 (2006.01); A61B 5/06 (2006.01); A61B 5/00 (2006.01); A61P 9/12 (2006.01); A61P 13/12 (2006.01); A61P 9/10 (2006.01); A61P 9/04 (2006.01); A61K 9/20 (2006.01); A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 49/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/401 (2013.01); A61B 5/068 (2013.01); A61B 5/073 (2013.01); A61B 5/4833 (2013.01); A61B 5/4839 (2013.01); A61K 9/1652 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/485 (2013.01); A61K 9/4816 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 49/00 (2013.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 13/12 (2018.01); A61B 2560/0204 (2013.01); A61B 2560/0214 (2013.01); A61B 2562/08 (2013.01); A61B 2562/12 (2013.01);
Abstract

Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.

Find Patent Forward Citations

Scheinpflug, Kurt. (2023). Lisinopril compositions with an ingestible event marker (U.S. Patent No. 11684605). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11684605

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…